webinar register page

Webinar banner
The Importance of Genetic Testing

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Jill Dolgin
Jill Dolgin, PharmD is the Head of Patient Advocacy at Applied Genetic Technologies Corporation (AGTC) which is a clinical-stage biotechnology company developing transformational genetic therapies for inherited retinal diseases. Dr. Dolgin leads the patient and professional engagement strategy to drive disease awareness and clinical trial recruitment efforts for the AGTC pipeline. She is responsible for incorporating the voice of the patient throughout drug development and corporate culture. She has over 20 years of global biopharmaceutical experience in Medical Affairs, Corporate Communications, Patient and Professional Advocacy, and Public Policy. Dr. Dolgin earned a Doctorate in Clinical Pharmacy from the University of the Sciences at Philadelphia and a Bachelor of Science degree in Pharmacy from The Ohio State University.
Jill Beis & Shari Shaw
Jill Beis is a genetic counsellor at Maritime Medical Genetics Services at the IWK Health Centre in Halifax, Nova Scotia. Jill Graduated from McGill University in 1990 and has worked in MMGS since 1992, with a brief hiatus from August 2001 to June 20003 to work as a research coordinator with Dr. Johane Robitaille in hereditary ocular disorders. Jill has a special interest in ocular genetics, neurogenetics, and sees patients/families in both pediatric and adult genetics clinics. Shari Shaw is the Health Information Officer at Fighting Blindness Canada, where she channels her passion for promoting health and wellness through knowledge translation and customer service. Prior to joining Fighting Blindness Canada in 2019, Shari worked in other health fields including cancer and cardiovascular health.
Dr. Cynthia Qian
Dr. Cynthia Qian is Assistant Professor, Ophthalmology at Université de Montréal & VP of the Canadian Retina Society. With her colleague Dr. Flavio Rezende, Cynthia successfully implanted the first “Bionic Eye” retinal prosthesis in the province of Quebec.